In both humans and experimental animals, dietary induced magnesium deficiency is correlated with insulin resistance. The purpose of this study was to determine whether dietary magnesium intake is associated with insulin sensitivity or blood pressure in a sample of nondiabetic, young adult black Americans. We also examined dietary calcium, potassium, and sodium intake. The study was conducted on a sample (n ‫؍‬ ‫؍‬ 179) of young adults aged 30 ؎ ؎ 3.4 years who had been followed longitudinally. Nutrient intake was assessed by obtaining a 24-h recall interview of dietary intake. Intake data were entered in a nutrient analysis program (Nutritionist III), which quantitated micronutrients, macronutrients, and minerals. We classified the sample into insulin-sensitive (IS) and insulin-resistant (IR) groups, according to insulinstimulated glucose use (M) measured during insulin clamp. M correlated positively with magnesium intake in mg/kg of fat-free mass (r ‫؍‬ ‫؍‬ 0.15, P < < .05 overall; in men, r ‫؍‬ ‫؍‬ 0.25, P < < .02). There was a significant negative correlation of total dietary magnesium intake with the sum of insulin levels measured during an oral glucose tolerance test (OGTT) (r ‫؍‬ ‫؍‬ ؊ ؊0.13, P < < .05). When corrected for body fat, in men there was also a significant correlation of dietary magnesium intake, measured in mg/kg of fat-free mass, with the sum of insulin concentrations on the OGTT (r ‫؍‬ ‫؍‬ ؊ ؊0.22, P < < .05). When cases were categorically classified as IS versus IR, magnesium intake in mg/kg of fat-free mass was lower in IR (2.97 ؎ ؎ 1.4) than in IS (3.68 ؎ ؎ 2.2; P ‫؍‬ ‫؍‬ .022). These results suggest a possible role for dietary magnesium in insulin resistance. Am J Hypertens 1999;12:747-756
A bnormalities in cellular ion homeostasis may be the link between cardiovascular and metabolic disease. 1 This unifying theory suggests that non-insulin-dependent diabetes (NIDDM), essential hypertension, left ventricular hypertrophy, atherosclerosis, and obesity all reflect different clinical manifestations of a common cellular lesion, characterized at least in part by reduced intracellular free magnesium and elevated cytosolic free calcium levels. 1 Disturbance in magnesium metabolism is widely recognized in diabetes, a disorder that is commonly associated with magnesium (Mg) deficiency. [2] [3] [4] The incidence of hypomagnesemia in diabetes mellitus has been reported to be from 25% to 39%. 4, 5 The mechanisms responsible for Mg deficiency in patients with diabetes are not completely known; however, reduced Mg intake in diabetics may be a significant contributor to Mg deficiency. 3, 6, 7 The Recommended Daily Allowance (RDA) of magnesium is 4.5 mg/kg/day for adults. Although a large percentage of the U.S. population is consuming amounts of Mg that are less than this level, 4 diabetics may be particularly at risk for dietary induced hypomagnesemia due to compounding factors such as urinary magnesium wasting, cell membrane hyperviscosity, and resultant transport abnormalities. 3, 9 Both intracellular and extracellular magnesium depletion are characteristics of type II diabetes. 2, 10, 11 Though no reports correlate intracellular magnesium concentration with dietary magnesium intake, Wein and Nadler, in an unpublished observation mentioned in a paper by Nadler and Rude, 4 suggest that there is an association between magnesium intake and intracellular free magnesium concentration in platelets of NIDDM subjects. In addition to magnesium intake and excretion, several other factors, such as gut absorption and cellular distribution, probably contribute to maintaining optimal concentrations of intra-and extracellular magnesium. 3, 12 Several hormones are thought to contribute to the regulation of cellular magnesium balance and transport: calcitonin, parathyroid hormone (PTH), norepinephrine, and epinephrine, but none of these seems to be as well defined as insulin in the cell membrane transport of magnesium and intracellular magnesium accumulation. 3, 13 Both the intracellular magnesium concentration and intracellular magnesium transport correlate with insulin-mediated glucose uptake. 13, 14 Hence, the intracellular accumulation of magnesium is dependent upon insulin action. Intracellular magnesium deficiency may be the consequence of insulin resistance, but the data of Paolisso et al 9 and Garland 12 suggest that magnesium deficiency may also worsen insulin resistance. Further support for this concept was recently published. 15 In vitro analysis of cells from essential hypertensives and normotensives demonstrated that basal levels of magnesium were lower in the cells of hypertensives, and that depletion of magnesium from cells of normotensives rendered them insulin resistant, and thus diminished intracellular magnesium uptake to the same degree as that of essential hypertensives.
Higher dietary intakes of magnesium, potassium, and calcium have been reported to increase insulin secretion and reduce blood glucose concentrations in experimental animal models and humans. 6 -8,16 -18 The purpose of this study was to determine whether dietary Mg intake is associated with insulin sensitivity or with blood pressure (BP) level in a sample of nondiabetic, young black Americans. We also examined dietary calcium, potassium, and sodium intakes.
MATERIALS AND METHODS
This study was conducted in a clinically healthy population of male and female black Americans. Each participant was drawn from a population that has been studied in ongoing investigations of BP regulation since adolescence. 19 -21 At enrollment for this study, the age range of the subjects was 20 to 42.9 years. Individuals with insulin-dependent diabetes mellitus (IDDM) or NIDDM were excluded. No subject was taking antihypertensive medications at the time of the study. We used an oral glucose tolerance test (OGTT) to measure plasma glucose and insulin concentration after a standard glucose challenge. A euglycemic hyperinsulinemic clamp procedure was used to quantify insulin-stimulated glucose utilization. Nutrition assessment was based on a 24-h dietary recall method. The protocol for this study was approved by the Institutional Review Board of the Medical College of Pennsylvania. Written informed consent was obtained from all participants at the time of enrollment.
Enrollment assessment consisted of physical examination, anthropometric measurements (height, weight, skinfold thickness, and circumference of arm, hips, thigh, and waist), BP determination, and dietary assessment. A 24-h dietary assessment was obtained through a personal recall interview before the metabolic testing. Subjects were notified before the recall interview that they would be prompted to remember their diet the next day. The same interviewer was used for all subjects. Dietary intake data were entered in a nutrient analysis program (Nutritionist III, N-Squared Computing, San Bruno, CA), which quantitated micronutrients, macronutrients, and minerals. From this we obtained total daily magnesium, calcium, potassium, and sodium intakes. After the interview, subjects were asked to continue their present eating habits. From the anthropometric measurements, percent body fat 22 and fat-free mass (FFM) 23 were calculated. Casual systolic (first phase) and diastolic (fifth phase) BP measurements were obtained by auscultation with a mercury column sphygmomanometer with subjects in the seated position after a 10-min rest period. The average of two determinations was used as the BP at the time of metabolic evaluation.
After the enrollment assessment, each subject returned to the clinical research unit for an OGTT that was scheduled in the morning after a 12-h fast. After a fasting blood sample was obtained, a 75-g glucose solution (Glucola, Ames Laboratories, Curtin Matheson Scientific, Houston, TX) was taken orally. Blood samples were obtained at 30, 60, and 120 min after ingestion of the glucose load. Each blood sample was immediately centrifuged. Plasma was removed and stored at Ϫ80°C until the samples were assayed for glucose and insulin concentrations.
Each subject returned to the clinical research unit for the euglycemic clamp procedure at 8 am after a 12-h overnight fast. The euglycemic hyperinsulinemic clamp was used to measure insulin-stimulated glucose utilization. 24, 25 During steady-state hyperinsulinemia, the glucose infusion rate required to maintain eugly-cemia quantified insulin-stimulated glucose metaboism (M, in milligrams/kilogram/minute). In both nonobese and obese young black men, we have demonstrated that with steady-state hyperinsulinemia at a level of 70 to 80 U/mL greater than fasting insulin level, endogenous glucose production is completely suppressed during the final 60 min of the procedure. 26 Because the target level of steady-state hyperinsulinemia in the present study was at least 70 to 80 U/mL greater than fasting insulin level, endogenous glucose production was completely suppressed, and the glucose infusion rate required to maintain euglycemia was an adequate index of total insulin-stimulated glucose use. 24 The euglycemic clamp procedure was conducted according to methods previously described. 27 In brief, the subject rested for at least 20 min after placement of venous catheters for infusion and sample withdrawal. Before the onset of euglycemic hyperinsulinemia, three samples were withdrawn for determination of fasting plasma glucose and fasting plasma insulin concentration. Euglycemic hyperinsulinemia was established with a primed constant infusion of insulin using the method of Rizza et al 24 to compute the priming dose and infusion rate of insulin. The target clamped-insulin concentration was 70 to 80 U/mL of insulin greater than fasting concentration, which is achieved with an infusion rate of mU/m 2 / min. 24 Glucose infusion was administered as 20% dextrose. The precise glucose concentration in the 20% dextrose stock solution was measured, and this value was used in the calculation of the glucose infusion rate with the negative feedback equation of DeFronzo et al. 25 A personal computer was programmed to use this iterative negative feedback equation, which was amended for 10-min plasma glucose sampling. Euglycemic hyperinsulinemia was maintained for 120 min. During the final 60 min of steady-state hyperinsulinemia, insulin-stimulated glucose concentration was determined from the glucose infusion rate. The coefficient of variation for clamped plasma glucose concentration was Ͻ5% during the final 60 min of the procedure. Insulin-stimulated glucose use was computed as the mean glucose infusion rate during the final 60 min of hyperinsulinemia and expressed as milligrams/kilogram/minute (M).
Glucose was administered as 20% dextrose in water (Abbott, Chicago, IL). Insulin (Eli Lilly, Indianapolis, IN) was mixed with normal saline to a concentration of 1000 mU/mL. All solutions were delivered by syringe pumps (Harvard model 22, South Natick, MA). Plasma glucose concentration was analyzed with the glucose oxidase technique (YSI model 27, Glucostat, Yellow Springs, OH). Plasma insulin concentration was determined with a solid-phase radioimmunoassay (Coat-ACount, Diagnostic Products Corp., Los Angeles, CA). Coefficients of variation for interassay and intraassay variability for glucose, insulin, and the lipid assays were Ͻ 5%.
Data Analysis
Univariate correlations among numerically continuous variables were examined by using Pearson correlation coefficients. Two-way ANOVA (gender v group) was used to test for significant differences in means (insulin-sensitive subjects versus insulin-resistant subjects, and men versus women). Tests for interactions were conducted between IS/IR groups and gender groups. We classified the study sample into insulin-sensitive (IS) and insulin-resistant (IR) groups according to the quantitative measurement of insulin-stimulated glucose uptake (M/I ϫ 100), where M/I is M adjusted for steady-state hyperinsulinemia (I). Subjects having M/I Ͻ 7.5 were considered insulin resistant. Subjects were classified as normotensive (BP Ͻ 135 mm Hg systolic and Ͻ 85 mm Hg diastolic) or borderline hypertensive (BP Ն 135 and Ͻ 150 mm Hg systolic or Ն 85 and Ͻ 96 mm Hg diastolic) on the basis of repeated measurements of BP. We used the sum of the insulin levels during the OGTT as the parameter in the categorical or continuous data analysis. Differences in means and interactions were considered statistically significant at P Ͻ .05.
RESULTS
Complete data sets were obtained for 179 subjects, including 90 men aged 30 Ϯ 3.4 years and 89 women aged 31 Ϯ 3.6 years. Table 1 provides the characteristics of this sample including age, height, weight, average systolic blood pressure (AVGSBP), average diastolic blood pressure (AVGDBP), body mass index (BMI), percent body fat, total body fat, and fat-free mass (FFM). Women had a higher BMI and percent body fat and less FFM. This corresponds with the greater prevalence of obesity in the women studied. Table 2 provides the mineral data for both men and women, including total milligrams in 24 h and milligrams per kilogram of FFM for magnesium, potas- sium, calcium, and sodium. The total 24-h intake was higher for each mineral in men than women, but, when corrected for FFM, was much more comparable. We examined the family history (mother, father, sibling, or self) of all subjects for diabetes mellitus (DM) and classified them as family history positive (FHϩ) or family history negative (FHϪ) for DM. Using this classification we found that 27% of the subjects reported FHϩ for DM. Two-way ANOVA comparing magnesium intake between the FHϩ or FHϪ groups showed no statistical significance. There may have been a limitation in our data collection because some members of the cohort could not provide a family history due to early parent or sibling death or separation. In addition, type II DM is often occult for many years before diagnosis, and thus there could have been error due to false-negative FH.
Results of the OGTT for men and women are provided in Figure 1 (glucose) and Figure 2 (insulin) . We examined the correlation between the metabolic and dietary variables using the Pearson correlation coefficient. There was a significant negative correlation between total dietary Mg intake (in milligrams) and the sum of insulin levels measured during the OGTT (r ϭ Ϫ0.13, P Ͻ .05). There were no significant correlations between total 24-h dietary magnesium intakes and insulin-stimulated glucose metabolism (M). However, when magnesium intake was corrected for adipose mass and expressed as magnesium in milligrams/ kilogram FFM, there was a direct correlation of M with magnesium intake for the entire population studied, men and women (r ϭ 0.10, P Ͻ .05). The total daily magnesium intake was lower in women then in men, in both IS (men, 243 mg v women, 158 mg), and IR groups (men, 218 mg v women, 160 mg), P Ͻ .001).
With adjustment for body fat, there were minimal gender differences in daily Mg intake (3.56 Ϯ 2.24 mg/kg FFM in men and 3.28 Ϯ 1.72 mg/kg FFM in women), as shown in Table 2 .
We conducted an analysis to compare Mg intake in IS and IR subjects. Table 3 lists the r values by gender for dietary magnesium and other minerals, as correlated with M. This correlation was strongest for potassium (r ϭ 0.29, P Ͻ .01 for men; r ϭ 0.06, P ϭ NS for women) but also significant for magnesium (r ϭ 0.25, P Ͻ .05 for men; r ϭ Ϫ0.04, P ϭ NS for women). Table 4 shows the correlation between dietary intake of Mg as milligrams/kilogram of FFM and plasma insulin levels during an OGTT at 0, 30, 60, and 120 min, respectively. Plasma insulin concentration at 120 min during the OGTT correlated significantly with magnesium intake (r ϭ Ϫ0.25, P Ͻ .02 for men; r ϭ Ϫ0.12, P ϭ NS for women). Figure 3 demonstrates that the sum of insulin secretion from all four points correlated significantly with 24-h dietary magnesium intake in men (r ϭ Ϫ0.22, P Ͻ .05). The relationship of higher plasma insulin with low dietary magnesium intake was significant for men but not for women.
To determine whether a relationship existed between impaired glucose tolerance and dietary magnesium, we first stratified the sample into normal glucose tolerance (NGT), impaired glucose tolerance (IGT), or DM according to OGTT criteria defined by the National Diabetes Data Group. 28 Using this classification for our sample of 179 cases, 25% had IGT and 2.7% were diabetic. We then examined the three glucose tolerance groups to determine if there were relationships between magnesium and IGT. There were no significant differences between the groups in magnesium per total calories or magnesium intake in mg/kg of FFM. Two-way ANOVA comparing magnesium intake in milligrams/kilogram FFM between BP groups showed no significant results. An ANOVA was also used to compare magnesium intake, as well as sodium, potassium, and calcium in milligrams/kilogram FFM, between IS and IR groups (Table 5) . Magnesium intake was significantly lower in IR than in IS (2.97 Ϯ 1.4 v 3.68 Ϯ 2.2 mg/kg FFM, P Ͻ .02) in the total sample. This difference, which is shown by gender in Table 3 , was greater in men than in women. When adjusted for FFM, there were also higher intakes of Na, K, and Ca in IS than in IR subjects. Results for Ca were not statistically significant. The total 24-h intake of Ca in men was 763.60 Ϯ 612.9 mg and in women was 505.85 Ϯ 266.66 mg; both were well below the RDA. Potassium intakes in milligrams/kilogram FFM were greater in IS than IR subjects, P Ͻ .05. Sodium intake in milligrams/kilogram FFM was also significantly greater in the IS group than the IR group in men and women. Most subjects had total 24-h sodium intakes Ͼ 3 g/day.
DISCUSSION
In this study on magnesium intake in black Americans, we found the average daily intake, based on a 24-h recall, to be 202 Ϯ 125 mg/day, a value that is much less than RDA. The dietary intake data also detected low calcium and potassium as well as high sodium intakes in these urban young adult black Americans. Very limited published data exist on di- 29, 30 Analysis of nutrient intake data from the Atherosclerosis Risk In Communities (ARIC) study in 15,248 subjects (ages 45 to 64 years), both black and white, showed that the black men consumed the lowest amounts of magnesium, and white women consumed the most. 30 Our study examined the relationship of unsupplemented dietary magnesium with blood pressure and insulin resistance, a prediabetic condition, in healthy young black Americans. No relationship between blood pressure and magnesium intake was detected. Insulin sensitivity, as determined by glucose tolerance and insulin clamp, correlated positively with magnesium intake. Most of the published data on magnesium intake and insulin sensitivity were obtained on supplemented versus unsupplemented subjects. Although our subjects were unsupplemented, and had wide variations in magnesium intake, there was a correlation of magnesium intake with insulin sensitivity. These findings are consistent with previous reports in unsupplemented humans. 6, 30 The ARIC study of 15,248 participants with equal white and black representation, and subjects aged 45 to 64 years, showed that dietary magnesium intake measured by the food frequency questionnaire was lower in blacks than whites, and inversely associated with fasting serum insulin and glucose. 30 The Nurses' Health Study cohort was used in an analysis of dietary nutrient intake and development of clinical diabetes. This study on 84,360 white, north American women aged 30 to 55 years who were followed for 6 years showed that diets highest in magnesium, potassium, and vegetable fat, as measured by the food frequency questionnaire, were associated with a reduced risk of diabetes. 6 Improved glucose handling during dietary magnesium supplementation has been well demonstrated in both human and experimental animal models of NIDDM. 7, 17, 18 Improvement in glucose handling has been demonstrated by Paolisso et al in elderly human NIDDM as well as in normal elderly subjects after oral magnesium supplementation for 4 weeks. 17, 18, 31 Experiments in rats have shown that dietary induced magnesium deficiency can predispose to glucose intolerance, and furthermore that magnesium replacement in the diet can prevent fructose-induced insulin resistance. 7, 16 Dietary induced hypomagnesemia in sheep led to decreased glucose-induced insulin secretion and decreased insulin-induced glucose uptake in Matsunobu et al's euglycemic clamp experiments. 32 In rat models of spontaneous NIDDM, Balon et al 16 demonstrated that magnesium supplements could prevent deterioration of glucose tolerance, but could not reverse diabetes once it had already started. Though there is currently no explanation on a cellular level, Paolisso et al proposed a theory to explain why glucose transport may be retarded in elderly humans with lower magnesium levels. These investigations suggested that reduced erythrocyte membrane fluidity, which reflects membrane lipid composition, may be a common cause for the changes seen in ion transport in essential hypertension and insulin resistance. 17 Lipid alterations in the cell membrane common to elderly humans and the fructose rat model could result in increased erythrocyte membrane viscosity and a tendency towards insulin resistance. 7, 17 In addition, it has been demonstrated that magnesium supplementation in these aged healthy humans increases erythrocyte magnesium concentration, decreases membrane microviscosity, and improves glucose handling, as measured by OGTT and insulin clamp. 17 Studies on intracellular magnesium concentrations in diabetic subjects have yielded consistent findings. Both type I and type II diabetics tend to have lower plasma and lower intracellular ionized magnesium concentrations. 2, 9, 33, 34 Paolisso et al 14 examined intracellular magnesium concentration in Pima Indians, a population at high risk for the development of NIDDM. They detected lower intracellular magnesium accumulation in response to insulin infusion during a euglycemic clamp in the prediabetic Pima Indians, as compared with whites. Alzaid et al 35 also reported that in insulin-resistant subjects with NIDDM, there is impaired ability of insulin to stimulate magnesium as well as glucose uptake. Overall, these experimental studies on dietary magnesium suggest that diets with foods high in magnesium, or magnesium supplementation, may retard the development of NIDDM in at-risk subjects.
Fasting levels of intracellular free magnesium are known to be lower in hypertensives than in normotensive subjects. 36 However, studies on an association between low dietary magnesium intake and blood pressure levels have had inconsistent results. 30, [37] [38] [39] Results of a study on dietary magnesium intakes and blood pressure in black and white adolescent girls 40 were inconclusive. There is a suggestion that the white girls with lower diastolic blood pressures had higher dietary magnesium intakes. However, when corrected for fiber intake, this association was no longer significant. Dietary cation intake was not associated with blood pressure in black girls. The inability to detect a relationship between blood pressure and magnesium intake may have been related to magnesium intakes that were greater than the RDA level in most subjects. The Nurses Health Study cohort is a predominantly white female population, aged 38 to 63 years. A food frequency questionnaire and a 4-year follow-up with regard to development of hypertension revealed that in the remaining normotensive subjects, there was an inverse relationship between blood pressure level and magnesium intakes. In the patients who developed hypertension, there was no relationship to magnesium intake. 39 A Dutch study using a food frequency questionnaire on 20,921 men and women aged 20 to 59 years old suggests that a diet high in magnesium is associated with lower blood pressures. 41 The ARIC study 30 examined serum and dietary magnesium intakes in 15,248 participants. The results from this study revealed a statistically significant number of hypertensives with low dietary magnesium intakes, especially in black men. The Honolulu heart study 37 concluded that foods such as vegetables, fruits, whole grains, and low-fat dairy items, which are foods high in magnesium, may be protective against hypertension. In this study of 615 Japanese men between the ages of 45 and 65 years who completed a 24-h dietary recall interview, the total magnesium intake was strongly and inversely associated with systolic and diastolic blood pressure. Our data revealed no statistically significant relationship between blood pressure and dietary magnesium intake. Our cohort was normotensive or at most borderline hypertensive. The clinical onset of diabetes often precedes that of hypertension, and thus this result in our sample of relatively young adults was not unexpected.
Previous studies have reported higher intakes of magnesium, calcium, and potassium in insulin-sensitive subjects, 6 and our results are consistent with those reports. However, we also observed that sodium intake was significantly higher in the IS subjects than in the IR subjects. This result raises the possibility of a limitation in diet data acquisition. Alternatively, if one considers hypertension and insulin resistance within a larger hormonal/ionic disequilibrium framework, as mentioned in the introduction, there may be some relevance to this intuitively erroneous result. Recent investigations into the incidence of acute myocardial infarction as it relates to sodium excretion (as a measure of dietary sodium) have revealed significantly lower Una excretion in patients with acute myocardial infarction followed over 3.8 years. 42 The authors suggest that sodium may be a marker for other protective substances such as calcium or iron in the diet. We cite this study with interest but also with caution, as insulin sensitivity was not measured during this study. It should also be noted that none of the diets from our study were low in sodium and that the mean for the entire group was 3637 Ϯ 1900 mg/day. In general, the cohort consumed diets low in magnesium and fiber, and high in processed and refined foods and sodium. Subjects with higher BMI had slightly lower Mg intakes. Because magnesium intake is correlated with total caloric intake, there may be some underreporting error. The major limitation of the dietary recall method is reliance upon memory 43 ; however, it has been demonstrated in some validated experiments to yield less total underreporting errors than 7-day dietary recall experiments. 44 In addition to errors related to memory, the accuracy of a 24-h dietary recall may vary across subgroups of a population; gender differences and BMI are known to affect the reporting of subjects during dietary recall. 45 Thin subjects and men may be predisposed due to social influences to overreport, in comparison with obese and female subjects, as observed during a validated 24-h diet intake experiment with a physiologic marker for protein content. Our cohort had a significant number of obese women and we expect that there may have been an underreporting error in this segment, thus limiting the accuracy of that data.
In summary, our data suggest that in young black Americans, diets low in magnesium may be associated with insulin resistance. To more fully evaluate the pathophysiology of the possible underlying transport abnormalities in insulin resistance, further studies are needed on intracellular and plasma magnesium concentrations, as well as studies on the metabolic effects of dietary magnesium supplementation.
